Year |
Citation |
Score |
2010 |
Homan K, Shah J, Gomez S, Gensler H, Karpiouk A, Brannon-Peppas L, Emelianov S. Silver nanosystems for photoacoustic imaging and image-guided therapy. Journal of Biomedical Optics. 15: 021316. PMID 20459238 DOI: 10.1117/1.3365937 |
0.329 |
|
2009 |
Doiron AL, Homan KA, Emelianov S, Brannon-Peppas L. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharmaceutical Research. 26: 674-82. PMID 19034628 DOI: 10.1007/S11095-008-9786-X |
0.303 |
|
2009 |
Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, Casciato S, Brannon-Peppas L. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. Journal of Biomedical Materials Research. Part A. 91: 263-76. PMID 18980197 DOI: 10.1002/Jbm.A.32247 |
0.626 |
|
2009 |
Betancourt T, Shah K, Brannon-Peppas L. Rhodamine-loaded poly(lactic-co-glycolic acid) nanoparticles for investigation of in vitro interactions with breast cancer cells. Journal of Materials Science. Materials in Medicine. 20: 387-95. PMID 18815729 DOI: 10.1007/S10856-008-3594-Z |
0.649 |
|
2009 |
Brannon-Peppas L, Blanchette JO. Corrigendum to "Nanoparticle and targeted systems for cancer therapy" [Advanced Drug Delivery Reviews 56(2004)1649-1659] (DOI:10.1016/j.addr.2004.02.014) Advanced Drug Delivery Reviews. 61: 364. DOI: 10.1016/J.Addr.2009.02.001 |
0.722 |
|
2008 |
Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews. 60: 1615-26. PMID 18840489 DOI: 10.1016/J.Addr.2008.08.005 |
0.612 |
|
2007 |
Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine (London, England). 2: 219-32. PMID 17716122 DOI: 10.2217/17435889.2.2.219 |
0.672 |
|
2007 |
Brannon-Peppas L, Ghosn B, Roy K, Cornetta K. Encapsulation of nucleic acids and opportunities for cancer treatment. Pharmaceutical Research. 24: 618-27. PMID 17372693 DOI: 10.1007/S11095-006-9208-X |
0.412 |
|
2006 |
Betancourt T, Brannon-Peppas L. Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices. International Journal of Nanomedicine. 1: 483-95. PMID 17722281 DOI: 10.2147/Nano.2006.1.4.483 |
0.574 |
|
2006 |
Brannon-Peppas L, Peppas NA. Dynamic and equilibrium swelling behaviour of pH-sensitive hydrogels containing 2-hydroxyethyl methacrylate1 The Biomaterials: Silver Jubilee Compendium. 51-60. DOI: 10.1016/0142-9612(90)90021-H |
0.445 |
|
2005 |
Betancourt T, Brown B, Brannon-Peppas L. Poly(lactide-co-glycolide) nanoparticles for controlled delivery of doxorubicin for the treatment of cancer Aiche Annual Meeting, Conference Proceedings. 8209-8213. |
0.596 |
|
2004 |
Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews. 56: 1649-59. PMID 15350294 DOI: 10.1016/J.Addr.2004.02.014 |
0.723 |
|
2004 |
Brannon-Peppas L, Soehl K, Monaco MD, Garlich J, Patterson M, Smith TC. Nanoparticles for delivery of pifithrins to combat cell death due to chemotherapy and radiation Journal of Drug Delivery Science and Technology. 14: 257-264. DOI: 10.1016/S1773-2247(04)50046-1 |
0.35 |
|
2003 |
Birnbaum DT, Brannon-Peppas L. Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl. Journal of Biomaterials Science. Polymer Edition. 14: 87-102. PMID 12635772 DOI: 10.1163/15685620360511155 |
0.381 |
|
2001 |
Brannon-Peppas L. Drug Targeting: Strategies, Principles and Applications Journal of Controlled Release. 75: 226. DOI: 10.1016/S0168-3659(01)00382-0 |
0.368 |
|
2000 |
Kosmala JD, Henthorn DB, Brannon-Peppas L. Preparation of interpenetrating networks of gelatin and dextran as degradable biomaterials. Biomaterials. 21: 2019-23. PMID 10966010 DOI: 10.1016/S0142-9612(00)00057-0 |
0.679 |
|
2000 |
Birnbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. Journal of Controlled Release : Official Journal of the Controlled Release Society. 65: 375-87. PMID 10699296 DOI: 10.1016/S0168-3659(99)00219-9 |
0.697 |
|
2000 |
Birnbaum DT, Kosmala JD, Brannon-Peppas L. Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles Journal of Nanoparticle Research. 2: 173-181. DOI: 10.1023/A:1010038908767 |
0.372 |
|
2000 |
Brannon-Peppas L. Poly(ethylene glycol): Chemistry and Biological Applications Journal of Controlled Release. 66: 321. DOI: 10.1016/S0168-3659(99)00212-6 |
0.358 |
|
2000 |
Brannon-Peppas L. Biodegradation and Bioremediation Journal of Controlled Release. 67: 418. DOI: 10.1016/S0168-3659(00)00220-0 |
0.316 |
|
1996 |
Anseth KS, Bowman CN, Brannon-Peppas L. Mechanical properties of hydrogels and their experimental determination. Biomaterials. 17: 1647-57. PMID 8866026 DOI: 10.1016/0142-9612(96)87644-7 |
0.489 |
|
1996 |
Brannon-Peppas L. Polymers in medicine and pharmacy Journal of Controlled Release. 42: 299. DOI: 10.1016/0168-3659(96)01460-5 |
0.327 |
|
1996 |
Peppas NA, Brannon-Peppas L. Controlled release of fragrances from polymers: I. Thermodynamic analysis Journal of Controlled Release. 40: 245-250. DOI: 10.1016/0168-3659(95)00191-3 |
0.496 |
|
1996 |
Brannon-Peppas L. Enzymatically degradable polymers based upon polysaccharides for controlled drug delivery Proceedings of the Controlled Release Society. 21-22. |
0.321 |
|
1996 |
Brannon-Peppas L. Polymers for biotechnology and bioengineering Asee Annual Conference Proceedings. 2575. |
0.325 |
|
1995 |
Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery International Journal of Pharmaceutics. 116: 1-9. DOI: 10.1016/0378-5173(94)00324-X |
0.483 |
|
1995 |
Brannon-Peppas L. Multiparticulate oral drug delivery Journal of Controlled Release. 34: 275-276. DOI: 10.1016/0168-3659(95)90053-5 |
0.36 |
|
1995 |
Brannon-Peppas L. Colloidal drug delivery systems Journal of Controlled Release. 37: 307-308. DOI: 10.1016/0168-3659(95)90003-9 |
0.389 |
|
1994 |
Brannon-Peppas L. Controlled release of β-estradiol from biodegradable microparticles within a silicone matrix Journal of Biomaterials Science, Polymer Edition. 5: 339-351. PMID 8025030 DOI: 10.1163/156856294X00068 |
0.328 |
|
1994 |
Peppas NA, Brannon-Peppas L. Water diffusion and sorption in amorphous macromolecular systems and foods Journal of Food Engineering. 22: 189-210. DOI: 10.1016/0260-8774(94)90030-2 |
0.43 |
|
1994 |
Brannon-Peppas L. Microcapsules and nanoparticles in medicine and pharmacy Journal of Controlled Release. 31: 307. DOI: 10.1016/0168-3659(94)90013-2 |
0.326 |
|
1993 |
Brannon-Peppas L. Novel vaginal drug release applications Advanced Drug Delivery Reviews. 11: 169-177. DOI: 10.1016/0169-409X(93)90031-X |
0.413 |
|
1993 |
Brannon-Peppas L, Peppas NA. Targeted drug delivery Journal of Controlled Release. 26: 241-242. DOI: 10.1016/0168-3659(93)90195-B |
0.519 |
|
1993 |
Brannon-Peppas L. Polymers in medicine biomedical and pharmaceutical applications Journal of Controlled Release. 26: 239-240. DOI: 10.1016/0168-3659(93)90192-8 |
0.342 |
|
1993 |
Brannon-Peppas L. Interactions of surfactants with polymers and proteins Journal of Controlled Release. 26: 148. DOI: 10.1016/0168-3659(93)90115-L |
0.303 |
|
1992 |
Brannon-Peppas L. Peptide and protein drug delivery Journal of Controlled Release. 20: 79. DOI: 10.1016/0168-3659(92)90141-D |
0.309 |
|
1992 |
Brannon-Peppas L. Design and mathematical analysis of controlled release from microsphere-containing polymeric implants Journal of Controlled Release. 20: 201-207. DOI: 10.1016/0168-3659(92)90122-8 |
0.348 |
|
1991 |
Brannon-Peppas L, Peppas NA. Time-dependent response of ionic polymer networks to pH and ionic strength changes International Journal of Pharmaceutics. 70: 53-57. DOI: 10.1016/0378-5173(91)90163-I |
0.474 |
|
1991 |
Brannon-Peppas L. Biodegradable polymers as drug delivery carriers Journal of Controlled Release. 17: 123. DOI: 10.1016/0168-3659(91)90138-4 |
0.435 |
|
1991 |
Brannon-Peppas L, Peppas NA. Equilibrium swelling behavior of dilute ionic hydrogels in electrolytic solutions Journal of Controlled Release. 16: 319-329. DOI: 10.1016/0168-3659(91)90009-3 |
0.497 |
|
1991 |
Brannon-Peppas L, Peppas NA. Equilibrium swelling behavior of pH-sensitive hydrogels Chemical Engineering Science. 46: 715-722. DOI: 10.1016/0009-2509(91)80177-Z |
0.485 |
|
1990 |
Brannon-Peppas L, Peppas NA. The Equilibrium Swelling Behavior of Porous and Non-Porous Hydrogels Studies in Polymer Science. 8: 67-102. DOI: 10.1016/B978-0-444-88654-5.50009-1 |
0.468 |
|
1990 |
Brannon-Peppas L. Preparation and Characterization of Crosslinked Hydrophilic Networks Studies in Polymer Science. 8: 45-66. DOI: 10.1016/B978-0-444-88654-5.50008-X |
0.359 |
|
1990 |
Peppas NA, Brannon-Peppas L. Hydrogels at critical conditions. Part 1. Thermodynamics and swelling behavior Journal of Membrane Science. 48: 281-290. DOI: 10.1016/0376-7388(90)85009-A |
0.427 |
|
1989 |
Brannon-Peppas L, Peppas NA. Solute and penetrant diffusion in swellable polymers. IX. The mechanisms of drug release from ph-sensitive swelling-controlled systems Journal of Controlled Release. 8: 267-274. DOI: 10.1016/0168-3659(89)90048-5 |
0.507 |
|
1988 |
Brannon-Peppas L, Peppas NA. Structural analysis of charged polymeric networks Polymer Bulletin. 20: 285-289. DOI: 10.1007/Bf00261982 |
0.443 |
|
Show low-probability matches. |